PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock?
Investors need to pay close attention to PTC stock based on the movements in the options market lately.
I've upgraded PTC Inc. to a Buy at ~$179 per share after strong FQ4 2025 results, robust customer contract growth, and improved shareholder returns. PTC's focus on product lifecycle management, strategic acquisitions, and divestiture of non-core assets positions it for sustained growth and operational efficiency. PTC demonstrates solid financials: rising revenue, expanding margins, strong free cash flow, and aggressive share buybacks, with valuation metrics favorable versus Autodesk.
PTC posts a stellar Q4 with EPS up 126% and revenue surging 43%, fueled by strong PLM and CAD growth and a sharper strategic focus.
PTC Inc. ( PTC ) Q4 2025 Earnings Call November 5, 2025 5:00 PM EST Company Participants Matthew Shimao - Senior Vice President of Investor Relations Neil Barua - President, CEO & Director Kristian Talvitie - Executive VP & CFO Robert Dahdah - Executive VP & Chief Revenue Officer Conference Call Participants Hoi-Fung Wong - Oppenheimer & Co. Inc., Research Division Jason Celino - KeyBanc Capital Markets Inc., Research Division Clarke Jeffries - Piper Sandler & Co., Research Division Blair Abernethy - Rosenblatt Securities Inc., Research Division Matthew Hedberg - RBC Capital Markets, Research Division Jay Vleeschhouwer - Griffin Securities, Inc., Research Division Tyler Radke - Citigroup Inc., Research Division Presentation Operator Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to PTC's 2025 Fourth Quarter Conference Call.
Besides Wall Street's top-and-bottom-line estimates for PTC Inc. (PTC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PTC Inc. (NASDAQ:PTC ) Inc. Citi's 2025 Global Technology, Media and Telecommunications Conference September 4, 2025 12:50 PM EDT Company Participants Neil Barua - President, CEO & Director Kristian Talvitie - Executive VP & CFO Conference Call Participants Tyler Radke - Citigroup Inc., Research Division Presentation Tyler Radke VP & Senior Analyst Good afternoon everyone. Tyler Radke here.
PTC Inc. (PTC) possesses solid growth attributes, which could help it handily outperform the market.
Company is positioned for growth with SEPHIENCE, approved for PKU in the US and Europe, and pending decisions in Japan and Brazil. Votoplam (PTC518) for Huntington's Disease shows promising phase 2 results; a key FDA meeting in Q4 2025 could enable Accelerated Approval and set a phase 3 trial design. Strong partnership with Novartis provides financial strength and development support for votoplam for treatment of HD patients, with up to $1.9 billion in milestone payments possible.
ZWS, SHG and PTC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 18, 2025.
PTC Inc. (PTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).